A Glimpse Inside the Lichen Planus Pipeline
Several new therapies are coming down the pike for the treatment of lichen planus, a chronic inflammatory condition that affects an estimated 1% to 2% of the global population, according to a new report from Research and Markets. There are currently no drugs specifically approved for lichen planus and available treatments are primarily palliative. […]